I am not a doctor, ours is a pediatric study, theirs is for adults, they have another phase 2/3 pediatric study in progress, it should be compared with that when the data comes out
https://www.anavex.com/anavex-life-...he-treatment-of-adult-patients-with-rett-syn/
https://www.neurenpharma.com/irm/PD...ificantclinicalbenefitinpediatricRettsyndrome
https://www.clinicaltrials.gov/ct2/...&cond=Rett Syndrome&draw=2&rank=1
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.02 |
Change
-0.260(1.82%) |
Mkt cap ! $1.745B | |||
| Open | High | Low | Value | Volume |
| $14.44 | $14.44 | $14.00 | $3.454M | 245.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 7440 | $14.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.11 | 3159 | 1 |
View Market Depth
| Last trade - 16.10pm 07/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |